Bleeding Complications With Dual Antiplatelet Therapy Among Patients With Stable Vascular Disease or Risk Factors for Vascular Disease | Zendy

Peter B. Berger | Zendy; Deepak L. Bhatt | Zendy; Valentı́n Fuster | Zendy; Philippe Gabríel Steg | Zendy; Keith A.A. Fox | Zendy; Mingyuan Shao | Zendy; Danielle M. Brennan | Zendy; Werner Hacke | Zendy; Gilles Montalescot | Zendy; Steven R. Steinhubl | Zendy; Eric J. Topol | Zendy

Open Access

Bleeding Complications With Dual Antiplatelet Therapy Among Patients With Stable Vascular Disease or Risk Factors for Vascular Disease

Author(s) -

Peter B. Berger,

Deepak L. Bhatt,

Valentı́n Fuster,

Philippe Gabríel Steg,

Keith A.A. Fox,

Mingyuan Shao,

Danielle M. Brennan,

Werner Hacke,

Gilles Montalescot,

Steven R. Steinhubl,

Eric J. Topol

Publication year - 2010

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.109.895342

Subject(s) - medicine , clopidogrel , aspirin , placebo , hazard ratio , vascular disease , population , surgery , cardiology , confidence interval , pathology , alternative medicine , environmental health

Uncertainty exists about the frequency, correlates, and clinical significance of bleeding with dual antiplatelet therapy (DAPT), particularly over an extended period in a stable population. We sought to determine the frequency and time course of bleeding with DAPT in patients with established vascular disease or risk factors only; identify correlates of bleeding; and determine whether bleeding is associated with mortality.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research